Heather Turner was Appointed as Senior Vice President and General Counsel at Sangamo

Date of management change: February 12, 2018 

What Happened?

Richmond, -based Sangamo Appointed Heather Turner as Senior Vice President and General Counsel


About the Company

Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients` lives using the company`s industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The Company is conducting Phase 1/2 clinical trials in Hemophilia A and Hemophilia B, and lysosomal storage disorders MPS I and MPS II. Sangamo has an exclusive, global collaboration and license agreement with Pfizer Inc. for gene therapy programs for Hemophilia A, with Bioverativ Inc. for hemoglobinopathies, including beta thalassemia and sickle cell disease, and with Shire International GmbH to develop therapeutics for Huntington`s disease. In addition, it has established strategic partnerships with companies in non-therapeutic applications of its technology, including Sigma-Aldrich Corporation and Dow AgroSciences.


About the Person

Heather Turner is Senior Vice President and General Counsel at Sangamo. Previously, Heather held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Roseman Paula, Varsellona Maria, Kelly Maureen, Peterson Sara, Kucinski Paul, Eidel Courtney, Kendris Thomas, Kandel Andrew, Turrin Liana, Lodge Shondra, Roberts Karen

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.